Trial · NCT04615702
Evidence Based Management of Acute Biliary Pancreatitis
NCT04615702, Completed, Zagazig University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Evidence Based Management of Acute Biliary Pancreatitis. Trials, record NCT04615702. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04615702
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Evidence Based Management of Acute Biliary Pancreatitis
- NCT number
- NCT04615702
- Status
- Completed
- Enrollment
- 30 participants, actual
- Lead sponsor
- Zagazig University
- Conditions
- Acute Pancreatitis
- Interventions
serum lipase or amylase, ultrasound, CT, Liver enzymes (Bilirubin, alanine transferase (ALT), aspartate aminotransferase, (AST) and alkaline phosphatase). Calcium. Triglycerides., EUS /Secretin-stimulated magnetic resonance cholangiopancreatography (MRCP), Ringer lactate, NSAID / paracetamol +/- opiates+/- epidural analgesia, Quinolones + Metronidazole /Carbapenems ± Metronidazole, Fresubin 2Kcal fiber drink, nasogastric tube, retroperitoneal necrosectomy, open necrosectomy, Endoscopic transmural cystogastrostomy, open cystogastrostomy, percutaneous catheter drainage (PCD) for infected necrosis, Endoscopic ultrasound (EUS) guided aspiration for infected necrosis
- First posted
- 2020-11-04
- Last updated
- 2020-11-05
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | success rate of minimally invasive techniques (percutaneaous catheter drainage, endoscopic approach and retroperitoneal approach) in cases with infected walled off necrosis | immediately following intervention to 6 weeks following intervention | Data were tabulated and statistically analyzed in terms of percentages Success of the intervention means patient condition improves \[clinical (vital signs) , laboratory (CBC, kidney and liver function tests) and radiological improvement (no residual collection in CT)\] and that there is no need for further intervention to control the disease till patient discharge |
| Primary | rate of complications of minimally invasive techniques used in the management of cases with infected walled off necrosis including bleeding, fistula, wound infection, incisional hernia | up to 6 months following intervention | Data were tabulated and statistically analyzed in terms of percentages |
| Primary | Mortality rate of acute biliary pancreatitis in the study period | from admission to 6 months following admission | Data were tabulated and statistically analyzed in terms of percentages |
| Primary | length of hospital stay of mild and severe cases with acute biliary pancreatitis | up to 6 months | Data were tabulated and statistically analyzed in terms of frequencies length of hospital stay in days |
| Secondary | age of cases with acute biliary pancreatitis in Sharqia in years | at admission | Data were tabulated and statistically analyzed in terms of mean |
| Secondary | Sex of cases with acute biliary pancreatitis in Sharqia (Males and females) | at admission | Data were tabulated and statistically analyzed in terms of percentages |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04615702
GET https://conductscience.org/api/trials/v1/NCT04615702/registered